Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

PCVXVaxcyte, Inc.

$8B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$18M

Net Income

-$17M

EPS (Diluted)

$-4.83

Cash Flow

Operating Cash Flow

-$14,963

Free Cash Flow

-$16,185

Stock-Based Comp.

$390

Balance Sheet

Total Assets

$40M

Total Liabilities

$9M

Stockholders' Equity

$31M

Cash & Equivalents

$36M

← FY 2018 All Quarters

PCVX FY 2017 Earnings — Vaxcyte, Inc. Revenue & Financial Results | Market Cap Arena